Loading provider…
Loading provider…
Neurology Physician in North Palm Beach, FL
NPI: 1457351934Primary Practice Location
Laszlo J. Mate, M.D., P.A.
824 US-1, North Palm Beach, FL
Primary Employer
Laszlo J. Mate, M.D., P.A.
matemd.com
HQ Phone
Get M.D. Laszlo's Phone Numberphone_androidMobile
Get M.D. Laszlo's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
1990 - 2026
CA State Medical License
1988 - 2023
OK State Medical License
1987 - 1989

American Board of Psychiatry and Neurology
Neurology with Special Qualification in Child Neurology
University Of Louisville School Of Medicine
louisville.edu
Residency • Pediatrics
1985 - 1987
Loma Linda University Health Education Consortium
Fellowship • Child Neurology
1988 - 1990
University of California (San Diego) Medical Center
Residency • Neurology
1987 - 1988
Semmelweis University
Medical School
Until 1978
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 59 | 119 |
| 2 | 95819Measurement and recording of brain wave (EEG) activity, awake and asleep | 22 | 24 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 20 | 20 |
Phase 1 and phase 2 metabolic activities along the small intestine in adult male sheep.
Authors: Maté, L, Virkel, G, Lifschitz, A, Sallovitz, J, Ballent, M, Lanusse, C
Journal: J Vet Pharmacol Ther
Regulation of gastric acid secretion by secretin and serotonin.
Authors: Mate, L, Sakamoto, T, Greeley, G H, Thompson, J C
Journal: Am J Surg
Authors: Ballent, M, Maté, L, Virkel, G, Sallovitz, J, Viviani, P, Lanusse, C, Lifschitz, A
Journal: J Vet Pharmacol Ther
Publication Date: 2014-03-10
Lead Sponsor: Avanir Pharmaceuticals
Intervention / Treatment: DRUG: Placebo, DRUG: AVP-923-45, DRUG: AVP-923-30, DRUG: AVP-923-20
Lead Sponsor: Ipsen
Intervention / Treatment: BIOLOGICAL: Botulinum toxin type A
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: Galcanezumab